Journal Pre-proof Morphological, biochemical and functional studies to evaluate bovine oocyte vitrification C. Gutnisky, S. Morado, T. Gadze, A. Donato, G. Alvarez, G. Dalvit, P. Cetica PII:
S0093-691X(19)30536-9
DOI:
https://doi.org/10.1016/j.theriogenology.2019.11.037
Reference:
THE 15272
To appear in:
Theriogenology
Received Date: 1 April 2019 Revised Date:
26 November 2019
Accepted Date: 29 November 2019
Please cite this article as: Gutnisky C, Morado S, Gadze T, Donato A, Alvarez G, Dalvit G, Cetica P, Morphological, biochemical and functional studies to evaluate bovine oocyte vitrification, Theriogenology (2019), doi: https://doi.org/10.1016/j.theriogenology.2019.11.037. This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article. Please note that, during the production process, errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain. © 2019 Published by Elsevier Inc.
Revised
1
Morphological, biochemical and functional studies to evaluate bovine
2
oocyte vitrification
3
Gutnisky C.1,2, Morado S. 1, Gadze T. 1, Donato A. 1, Alvarez G. 1,2, Dalvit
4
G. 1 and Cetica P. 1,2
5
1
6
Investigación y Tecnología en Reproducción Animal (INITRA) and 2 Unidad Ejecutora
7
de Investigaciones en Producción Animal (INPA, UBA-CONICET), Buenos Aires,
8
Argentina.
9
Universidad de Buenos Aires, Facultad de Ciencias Veterinarias, Instituto de
Corresponding author:
10
Cynthia Gutnisky
11
Cátedra de Química Biológica
12
Facultad de Ciencias Veterinarias
13
Universidad de Buenos Aires
14
Chorroarín 280
15
C1427CWO Buenos Aires
16
ARGENTINA
17
Tel/FAX: 0054-11-45248452
18
[email protected]
19 20
Abstract
21
The aim of the present study was to evaluate the effect of vitrification on
22
morphological, biochemical and functional parameters of matured bovine oocytes at
23
different recovery times. To this end, matured bovine oocytes were vitrified using
24
the Cryotech® kit (a minimum-volume system) and then incubated in maturation
25
medium for different post-warming durations (0 h, 3 h or 21 h). Morphology,
26
viability and biochemical parameters were assessed at each time point mentioned
27
above and the recovery of the metaphase plate was analyzed at 2 h, 3 h and 4 h post-
28
warming. The vitrification-warming process did not affect the viability or
29
morphology of oocytes at any time point. However, the recovery of the metaphase
30
plate occurred mostly between 3 and 4 h rather than at 2 h after warming (P<0.05).
31
Both control and vitrified-warmed oocytes showed changes in cytosolic oxidative
32
activity, quantification of active mitochondria, reactive oxygen species (ROS) levels
33
and redox status at the different time points studied (P<0.05). However, differences
34
between control and vitrified-warmed oocytes were found only in the quantification
35
of active mitochondria and ROS production (P<0.05). Finally, in vitro fertilization
36
and embryo culture were carried out as functional studies to establish whether
37
vitrification-warming affected oocyte competence, and a significant decrease was
38
found both in the cleavage rate and embryo development (P<0.05). We concluded
39
that major improvements in oocyte vitrification, at list with Cryotech® kit, are still
40
needed to avoid variations in oocyte metabolism which could contribute to the
41
reduction in the developmental competence of bovine oocytes.
42 43
Key words: cryopreservation, oocyte, Cryotech®, mitochondria, redox state
44 45
1. Introduction
46
Vitrification has become a technique routinely used in most human fertility
47
clinics to cryopreserve embryos and oocytes. However, this method is still not
48
commonly applied in animal breeding programs. Briefly, vitrification involves ultra-
49
rapid cooling in small volumes of highly viscous solutions containing relatively high
50
cryoprotectant concentrations, which results in the formation of a glass-like state both
2
51
inside and outside the cell, thus avoiding crystallization. Although at long exposure
52
times these cryoprotectants at high concentrations could induce cellular injuries, mainly
53
due to toxicity and osmotic stress [1], vitrification has improved the survival rates of
54
bovine embryos respect to the slow-freezing technique [2-4], becoming a possible
55
alternative for their cryopreservation. However, no satisfactory results have yet been
56
achieved for the bovine female gamete [5]. Although many advances have been made
57
regarding the cryopreservation of mature and immature bovine oocytes, vitrification is
58
still not considered an established procedure.
59
Vitrified oocytes may present several abnormalities related to a decrease in
60
their competence, including alterations in their cytoskeleton, an increase in
61
cytoplasmic Ca++ ion, and the hardening of the zona pellucida [6-8]. In line with
62
these findings, after vitrification, the secondary structure of proteins suffers
63
rearrangements, indicated by the increase in the β-sheet content at the expense of
64
the α-helices, as well as the lipid and carbohydrate configuration of the zona
65
pellucida [7]. Additionally, mitochondrial damages and alterations in their
66
distribution and function have been observed [9, 10]. On the other hand, oocyte
67
vitrification-warming leads to cell abnormalities that might be reversible, being the
68
post-warming recovery crucial for the improvement of the process. In mice, it has
69
been demonstrated that the incubation for 2 or 3 h results in higher percentages of
70
normal meiotic spindles than the incubation for only 1 h [11].
71
Several reports have demonstrated that vitrification may disturb the reduction-
72
oxidation (redox) status, reduce glutathione (GSH) content and increase reactive oxygen
73
species (ROS) levels, resulting in damage to biomolecules such as DNA, proteins and
74
membrane lipids and leading to mitochondrial dysfunction, which may induce apoptotic
75
responses and reduce cleavage and embryo viability [12-14]. Since GSH is related to the
3
76
reduction of disulfide bonds in the sperm nucleus and promotes its decondensation
77
inside the male pronucleus during fertilization, alterations in GSH content during
78
vitrification may affect cleavage by preventing the formation of the male pronucleus
79
[15, 16]. However, more studies about the changes in biochemical parameters after
80
oocyte vitrification need to be carried out.
81
Results regarding oocyte vitrification differ among species because of the
82
differences between the female gametes. In the human clinic, women’s oocytes have
83
been vitrified successfully, showing high survival percentages and no alterations in their
84
ultrastructure [17, 18]. This is the reason why, as explained above, the cryopreservation
85
technique is currently routinely used in most human fertility clinics. One of the
86
minimum-volume vitrification methods most used for human oocytes, due to its high
87
efficiency, is Cryotech® [19, 20]. However, this method has not yet been assessed for
88
bovine oocytes. Therefore, the aim of the present study was to evaluate the effect of
89
vitrification on morphological, biochemical and functional parameters of bovine oocytes
90
by using Cryotech® and by evaluating different post-warming durations of the in vitro
91
culture.
92 93 94 95 96
2. Materials and methods 2.1. Materials Unless specified, all chemicals and reagents were purchased from Sigma (Sigma Chemical Co., St. Louis, MO, USA).
97 98
2.2. Recovery of cumulus-oocyte complexes
99
Bovine ovaries were collected at an abattoir within 30 min after slaughter and
100
kept warm (30ºC) during the 2-h journey to the laboratory. Ovaries were washed with
101
physiological saline containing 100,000 IU L-1 penicillin and 100 mg L-1 streptomycin. 4
102
Cumulus-oocyte complexes (COCs) were recovered by aspiration of antral follicles (3 -
103
5 mm in diameter) and collected directly in the maturation medium described in item
104
2.3. COCs were washed three times before being placed in the definitive maturation
105
medium. Only oocytes surrounded by a compact and multilayered cumulus oophorus
106
were used.
107 108
2.3. In vitro maturation of cumulus-oocyte complexes
109
COCs were cultured in medium 199 (Earle’s salts, L-glutamine, 2.2 mg L-1
110
sodium bicarbonate; GIBCO, Grand Island, NY, USA) supplemented with 5% (v/v)
111
fetal bovine serum (FBS; GIBCO), 0.2 mg L-1 porcine FSH (Folltropin-V; Bioniche,
112
Belleville, Ontario, Canada), 2 mg L-1 porcine LH (Lutropin-V; Bioniche) and 50 mg
113
L-1 gentamicin sulfate under mineral oil at 39ºC for 22 h in a humidified atmosphere
114
containing 5% CO2 in air.
115 116 117
2.4. Oocyte preparation Unless specified, matured oocytes were partially denuded by repeated pipetting
118
in phosphate buffer saline (PBS) with 1 g L-1 hyaluronidase. External cumulus cells
119
were removed maintaining the corona radiata.
120 121
2.5. Oocyte vitrification
122
After 22 h maturation, partially denuded oocytes were vitrified using the
123
Cryotech® vitrification kit. Groups of five oocytes were placed in an equilibration
124
solution provided with the kit. At first, oocytes shrank due to the high osmolarity of
125
this solution, but once they fully recovered their normal morphology, they were
126
moved to the vitrification solution provided with the kit. The whole process took
5
127
between 9 and 11 min (8 to 10 min to recover their normal morphology in the
128
equilibration solution and 1 min in the vitrification solution). Oocytes were then
129
loaded in groups of five oocytes with a glass capillary onto the top of the film strip
130
supplied with the kit with a minimum volume of vitrification medium (less than 1
131
µL per oocyte) and the sample was quickly immersed into liquid nitrogen and
132
covered with a protective cap. Oocytes were maintained in liquid nitrogen for 1
133
week before warming.
134
For the warming procedure, the protective cap was removed and the film
135
strips containing the groups of five oocytes were removed from the liquid nitrogen
136
and directly introduced in the warming solution provided with the Cryotech® kit at
137
37º C for 1 min. Then, the oocytes were consecutive moved to different solutions.
138
Firstly, oocytes were placed in the dilution solution for 3 min and then moved to two
139
consecutive washing solutions provided with the kit for 5 min and 1 min,
140
respectively. After warming, oocytes were cultured in medium 199 (Earle’s salts, L-
141
glutamine, 2.2 mgL-1 sodium bicarbonate; GIBCO, Grand Island, NY, USA) as it
142
was described above.
143 144
2.6. Evaluation of the oocyte morphology and viability
145
Vitrified-warmed oocytes were evaluated at three different time points:
146
immediately after warming (0 h); at 3 h post-warming for their metabolic recovery,
147
and at 21 h post-warming, being this the time required for the formation of pronuclei
148
after fertilization. For each time point, a group of 15 oocytes was removed from the
149
medium for their evaluation and then discarded. Controls were performed using
150
matured non-vitrified oocytes left in the maturation medium during the same time
6
151
points. For morphological and biochemical evaluations, oocytes were taken from the
152
same batch of ovaries and processed separately (Fig. 1).
153 154
2.6.1. Morphological evaluation
155
The morphology of vitrified-warmed and control oocytes was evaluated
156
subjectively under a stereoscopic microscope with differential interferential contrast
157
with base on their cytoplasmic structure and volume recovery, as well as on the
158
integrity and definition of their plasma membrane, zona pellucida and perivitelline
159
space (n=98-103 oocytes for each group in three replicates). Oocytes with
160
asymmetric or irregular forms, increased perivitelline space or presence of
161
granularity in their cytoplasm were classified as abnormal.
162 163
2.6.2. Viability evaluation
164
The viability of vitrified-warmed and control oocytes was determined using
165
the fluorescein diacetate (FDA) fluorochrome. Oocytes were incubated in a solution
166
containing 0.12 µM FDA for 15 min. After incubation, they were washed twice in a
167
PBS + 0.1% polyvinyl alcohol (PVA) solution and loaded on a glass slide for their
168
observation under an epifluorescent microscope [21] (n=96 oocytes for each group,
169
i.e. control and vitrified-warmed oocytes, in three replicates).
170 171 172 173
2.7. Biochemical evaluations Vitrified-warmed and control oocytes were evaluated at the same time points described above.
174 175
2.7.1. Cytosolic oxidative status and quantification of active mitochondria
7
176 177
For these experiments, the zona pellucida was dissolved with 5 g L-1 pronase solution for 1 min.
178
The RedoxSensor Red and Mitotracker Green dual stain was used to evaluate
179
the cytosolic oxidative activity and to quantify active mitochondria of vitrified-
180
warmed and control oocytes. Cells were incubated for 30 min in the dark, at a final
181
concentration of 1 nM RedoxSensor Red and 0.5 nM Mitotracker Green, then
182
washed twice in PBS + 0.1% PVA and loaded on a glass slide for their observation
183
under an epifluorescent microscope. Microphotographs were taken and oocyte
184
fluorescence intensity was analyzed with IMAGE J software [22] (n=30–40 oocytes
185
for each treatment in three replicates; Fig. 2). No autofluorescence was detected
186
without either of the two fluorochromes with their respective filters.
187 188
2.7.2. Determination of reactive oxygen species levels
189
Denuded oocytes were incubated with 5 µM 2’,7’-dichlorodihydro-
190
fluorescein diacetate (DCHFDA) solution in PBS + 0.1% PVA for 30 min. To
191
analyze esterase activity, a group of oocytes was incubated in a solution containing
192
0.12 µM FDA for 15 min. After the exposure of both groups of oocytes to their
193
respective fluorochrome, they were washed twice in a PBS + 0.1% PVA solution
194
and loaded on a glass slide for their observation using an epifluorescent microscope.
195
Microphotographs were taken and oocyte fluorescence intensity was analyzed using
196
IMAGE J software. The ratio between DCHFDA fluorescence intensity for each
197
oocyte and the mean FDA fluorescence intensity for each treatment was used as an
198
estimate of ROS production per oocyte [23] (n=30–40 oocytes for each treatment
199
group in three replicates; Fig. 2).
200
8
2.7.3. Determination of the redox state
201
The
202
oocyte
redox
state
was
determined
measuring
NAD(P)H
203
autofluorescence using a blue filter (excitation 405 nm, emission 420-520 nm).
204
Microphotographs were taken and the fluorescence intensity was analyzed with
205
IMAGE J software [24] (n=30–40 oocytes for each treatment in three replicates; Fig.
206
2).
207 208 209
2.8. Oocyte functional studies 2.8.1. Analysis of metaphase II plate recovery
210
Before they may be activated by in vitro fertilization (IVF) or chemical
211
activation, vitrified-warmed oocytes must first recover their metaphase II chromosome
212
configuration. So, to study metaphasic plate recovery time, vitrified-warmed oocytes
213
were incubated for 2, 3 or 4 h in the same medium used for oocyte maturation. After
214
incubation, denuded oocytes were fixed in 40 mg L-1 paraformaldehyde solution for 1 h.
215
Finally, the fixed oocytes were stained with 10 mg L-1 Hoechst 33342 solution for 15
216
min. The oocyte nuclear status was observed at a x400 magnification, using 330–380
217
nm (excitation) and 410 nm (emission) filters for a Jenamed II epifluorescence
218
microscope (Carl Zeiss Jena, Buenos Aires, Argentina) to establish the time point when
219
most of the metaphase plates appear [25]. The nuclear material that was not condensed
220
as metaphase II was considered as unrecovered (Fig. 3) (n=20-26 in two replicates).
221 222
2.8.2. In vitro fertilization and embryo development
223
To study the competence of in vitro matured vitrified-warmed oocytes, we
224
analyzed their ability to be fertilized and develop to blastocyst stage. To this end, three
225
groups of in vitro matured oocytes were fertilized: oocytes surrounded by cumulus cells
9
226
(IVF control), partially denuded oocytes (control) and vitrified-warmed partially
227
denuded oocytes (treatment). All the groups were incubated for 3 additional hours
228
before insemination to allow the metaphase II plate of vitrified oocytes to recover.
229
IVF was performed using frozen–thawed semen from a Holstein bull of proven
230
fertility. Semen was thawed at 37ºC in a water bath, then resuspended in modified
231
synthetic oviductal fluid (mSOF) (sodium chloride 107.7 mM, potassium chloride 7.16
232
mM, potassium monobasic phosphate 1.19 mM, calcium chloride 1.71 mM, magnesium
233
chloride 0.49 mM, sodium bicarbonate 25.07 mM, sodium lactate 3.30 mM, and sodium
234
pyruvate 0.30 mM) [26], centrifuged twice at 500 g for 5 min and then resuspended in
235
fertilization medium to a final concentration of 2×106 motile spermatozoa mL−1 after the
236
swim-up procedure [27], each well was inseminated with 5 x 105 motile spermatozoa.
237
Sperm concentration was determined by hemocytometry using a Neubauer chamber,
238
and an average of the count of both chambers was used for each determination. Motility
239
was evaluated three times by the same observer by using an optical microscope
240
equipped with a thermal stage at 37ºC. Fertilization was performed in 500 µL IVF-
241
mSOF (mSOF supplemented with bovine serum albumin (BSA) 3 g L-1 and heparin
242
10000 U L-1) under mineral oil at 39ºC, in 5% CO2 in air for 20 h. Putative zygotes were
243
denuded by repeated pipetting and placed in 500 µL in vitro culture (IVC)-mSOF,
244
consisting of mSOF supplemented with 30 mL L−1 amino acid MEM (GIBCO), 10 mL
245
L−1 non-essential amino acid MEM (GIBCO), 2 mmol-glutamine, 6 g L−1 BSA and 5%
246
(v/v) FBS (GIBCO), under mineral oil at 39ºC in a humidified atmosphere with 90%
247
N2:5% CO2:5% O2 for 24 h. The proportion of cleaved embryos after 48 h was
248
evaluated by the number of embryos that presented two or more blastomeres.
249
In vitro embryo development was performed in IVC-mSOF, under mineral oil at
250
39ºC in a humidified atmosphere with 90% N2:5% CO2:5% O2, renewing the culture
10
251
medium every 48 h. The proportion of blastocysts produced was determined on days 7
252
and 8 following insemination (n=73–98 for each treatment in three replicates).
253 254
2.8.3. Parthenogenetic activation
255
Next, to study the activation capacity of in vitro matured vitrified-warmed
256
oocytes independently of spermatozoa, we analyzed their ability to be chemically
257
activated. To this end, matured fresh oocytes and vitrified-warmed oocytes were
258
completely denuded and then incubated in TALP (sodium chloride 114 mM, potassium
259
chloride 3.2 mM, sodium monobasic phosphate 0.3 mM, calcium chloride 2 mM,
260
magnesium chloride 0.5 mM, sodium bicarbonate 25.00 mM, sodium lactate 10 mM,
261
and sodium pyruvate 0.20 mM) supplemented with 3 g L-1 BSA and 5 µM ionomycin
262
for 5 min and then in mSOF added with 2 mM 6-dimethylaminopurine for 3 h as
263
described by Grupen et al. [28]. Oocytes were then washed and placed in IVF-mSOF
264
under mineral oil in a humidified atmosphere with 90% N2: 5% CO2: 5% O2 for 45 h.
265
The percentage of cleaved embryos was determined as described above (n= 114 oocytes
266
for each treatment, in two replicates).
267 268
2.9. Experimental design
269
For the morphological, viability and biochemical evaluation, COCs were
270
randomly divided into two groups: control and vitrified-warmed oocytes, whereas for
271
the functional studies, COCs were randomly divided in three groups after maturation:
272
control and vitrified-warmed oocytes, and an additional group representing an IVF
273
control consisting of COCs completely surrounded by cumulus cells. For the
274
morphological, viability and biochemical evaluation, control and vitrified-warmed
275
oocytes came from the same batch of ovaries but were processed at different times
11
276
because of the extra time needed by the vitrification-warming process. For the
277
functional studies, control oocytes came from a different batch of ovaries to synchronize
278
the warming time with the completion of maturation (Fig. 1).
279 280
2.10. Statistical analysis
281
The cytosolic oxidative status, quantification of active mitochondria, ROS
282
production and redox state values were expressed as mean ± S.E.M. and interactions
283
were analyzed by two-way ANOVA, using post-hoc general contrasts for
284
comparison among treatments (2x3 factorial analysis). All statistical tests were
285
performed using the InfoStat software (Universidad de Córdoba, Córdoba,
286
Argentina, see http://www.infostat.com.ar).
287
Metaphase II plate recovery, cleavage and embryo development rates were
288
compared using a chi-square analysis for non-parametric data. P<0.05 was
289
considered significant.
290 291 292
3. Results 3.1. Evaluation of the oocyte morphology and viability
293
At 0 (n= 28) and 3 h (n=43) of incubation, all the vitrified-warmed oocytes
294
studied conserved a normal morphology, preserving their plasma membrane
295
integrity, a reconstructed perivitelline space and a uniform cytoplasm, while at 21 h
296
of incubation, 94% (n=32) of the oocytes remained with the normal characteristics
297
described above. No differences were observed between vitrified-warmed oocytes
298
and controls (n = 98; 0 h =30; 3 h = 34; 21 h= 34 oocytes, in three replicates).
299
Regarding their survival capacity, vitrified-warmed oocytes showed 100%
300
viability for the three time points studied. No differences were observed between
12
301
controls and vitrified oocytes (n = 192; 0 h =32; 3 h = 32; 21 h= 32 oocytes for each
302
group, in three replicates).
303 304 305 306
3.2. Biochemical evaluations 3.2.1. Cytosolic oxidative status and quantification of active mitochondria
307
Differences in oxidative activities were observed in both groups at the
308
different time points studied. A decrease in oxidative activity was recorded in the
309
vitrified-warmed group at 3 and 21 h and in the control group at 3 h compared with
310
0 h (P<0.05), while no differences were observed between treatments (Fig. 4a)
311
(mean ± SEM: control 0 h 2.59 x 106± 2.56 x 105 vs. vitrified-warmed oocytes 0 h
312
2.85 x 106± 2.91 x 105; control 3 h 1.73 x 106± 1.24 x 105 vs. vitrified-warmed
313
oocytes 3 h 1.84 x 106± 1.89 x 105; control 21 h 2.12 x 106± 1.87 x 105 vs. vitrified-
314
warmed oocytes 21 h 1.84 x 106± 1.89 x 105).
315
As regards the quantification of active mitochondria, significant differences
316
were observed along the time points studied and between treatments. The control
317
group showed an increase in the quantification of active mitochondria at 21 h respect
318
to that at 3 h, while vitrified-warmed oocytes showed a decrease at 3 h and 21 h
319
compared to that at 0 h (P<0.05). Also, an increase in the quantification of active
320
mitochondria was observed at 0 and 3 h in vitrified-warmed oocytes compared with
321
their respective controls (P<0.05) (Fig. 4b) (mean ± SEM: control 0 h 1.28 x 107 ±
322
7.28 x 105 vs. vitrified-warmed oocytes 0 h 1.64 x 107± 1.10 x 106; control 3 h 1.08
323
x 107± 5.02 x 105 vs. vitrified-warmed oocytes 3 h 1.35 x 107± 9.30 x 105; control 21
324
h 1.38 x 107± 1.54 x 106 vs. vitrified-warmed oocytes 21 h 1.35 x 107± 1.08 x 106).
325
13
326
3.2.2. Reactive oxygen species levels
327
Vitrified-warmed and control oocytes showed variations in ROS production
328
at the different time points studied. ROS levels were higher in vitrified-warmed
329
oocytes than in the control oocytes at 0 h, and higher in control oocytes at 0 h than
330
in control ones at 3 h and 21 h (P<0.05) (Fig. 5) (mean ± SEM: control 0 h 521.1 ±
331
37.75 vs. vitrified-warmed oocytes 0 h 617.37 ± 69.43; control 3 h 339.29 ± 25.12
332
vs. vitrified-warmed oocytes 3 h 244 ± 10.17; control 21 h 4.15 ± 26.87 vs. vitrified-
333
warmed oocytes 21 h 259.32 ± 19.85).
334 335
3.2.3. Redox state
336
An increase in the redox state at 21 h was observed in both control and
337
vitrified-warmed oocytes (P<0.05), but no differences were detected between
338
treatments (Fig. 6) (mean ± SEM: control 0 h 3.35 x 106± 1.96 x 105 vs. vitrified-
339
warmed oocytes 0 h 4.03 x 106± 3.60 x 105; control 3 h 3.61 x 106± 2.49 x 105 vs.
340
vitrified-warmed oocytes 3 h 3.89 x 105± 1.89 x 105; control 21 h 5.40 x 106± 5.56 x
341
105 vs. vitrified-warmed oocytes 21 h 4.91 x 106± 5.90 x 105).
342 343 344
3.3 Oocyte functional studies 3.3.1 Metaphase II plate recovery analysis
345
The metaphase II configuration recovered 3 hours after warming (69.2%). No
346
further improvement was found after 4 hours of incubation (61.5%), while 2 hours of
347
incubation post-warming proved to be insufficient (10 %; P<0.05; Table 1).
Metaphase II (%) Unrecovered nuclear material n
2 hours
3 hours
4 hours
2 (10)a 18 20
18 (69.2)b 8 26
16 (61.5)b 10 26
348 14
349
Table 1. Metaphase II plate recovery of vitrified-warmed oocytes incubated for 2, 3 and
350
4 hours. Numbers in parentheses are percentages. Different superscript letters indicate
351
significant differences in the percentage of oocytes at different time points (n=20-26 per
352
group in two replicates, P<0.05).
353 354
3.4. In vitro fertilization and embryo development
355
Significant differences between the three previously described groups (IVF
356
control, control and treatment) were observed in the cleavage and blastocyst rates,
357
with vitrified-warmed oocytes showing a decrease in both parameters (cleavage
358
rates for IVF control, control and vitrified-warmed oocytes: 79.6%, 57.4% and
359
31.18%, respectively; blastocyst rates for IVF control, control and vitrified-warmed
360
oocytes: 35.5%, 18.2% and 8.8%, respectively) (P<0.05; Table 2).
IVF Control Control Vitrified-warmed
Number of oocytes used for IVF
Number (%) of cleaved embryos
Number of embryos (%) developed to blastocyt stage
118 115 125
94 (79.6) a 66 (57.4) b 39 (31.18) c
42 (35.5) a 21 (18.2) b 11 (8.8) c
361 362
Table 2. Cleavage and blastocyst rates following IVF. Numbers in parentheses are
363
percentages. Different superscript letters indicate significant differences in the
364
percentage of cleaved embryos and number of embryos developed to blastocyst on days
365
2 and 7- 8 respectively, P<0.05).
366 367
3.5. Parthenogenetic activation
368
Parthenogenetic activation was performed to analyze the cause of the
369
reduction in the cleavage rate observed in vitrified-warmed oocytes after IVF.
370
Denuded oocytes (controls) and vitrified-warmed denuded oocytes were chemically 15
371
activated and the cleavage rate was evaluated after 48 hours in both groups, showing
372
no significant differences (control: 55.4 % vs. vitrified-warmed oocytes: 50 %; n=
373
57 oocytes per group, in two replicates).
374 375
4.
Discussion
376
Although in the last decade many studies have been conducted to improve
377
embryo and oocyte vitrification, this technique is not currently used for oocytes in
378
animal breeding programs. Our goal was to study the effect of bovine oocyte
379
vitrification using the Cryotech® method on morphological, biochemical and
380
functional parameters at different recovery times to assess the ability of oocytes to
381
recover from the damages induced by vitrification.
382
By analyzing ultrastructural morphological parameters, several authors have
383
previously concluded that vitrification may affect nuclear morphology [29],
384
microtubule formation [30], cytoplasmic organization [29, 31], and membrane
385
integrity [32]. So, in the present study, we first determined oocyte morphology and
386
viability in matured vitrified and control bovine oocytes along 21 h of extended
387
incubation and observed no differences between the groups studied, thus
388
demonstrating that Cryotech® did not affect oocyte macromorphology and viability.
389
We then evaluated biochemical parameters in control and vitrified oocytes.
390
Although we found no differences in the cytosolic oxidative activity between
391
groups, vitrified oocytes presented an increase in the quantification of active
392
mitochondria at 0 and 3 h after warming. This increase may be a consequence of a
393
higher energy requirement for the reorganization of organelles, cytoplasm and redox
394
potential after oocyte vitrification-warming. In previous studies on porcine oocyte in
395
vitro maturation, we observed that the quantification of active mitochondria is
16
396
modulated by ATP or AMP [22]. Similarly, by evaluating mitochondrial activity
397
with Mitotracker Red CMXRos, Succu et al. described high mitochondrial activity
398
and low ATP content after warming of vitrified oocytes [33].
399
As regards ROS levels, some reports have described an increase in this
400
parameter in vitrified oocytes after warming [33-35]. We also found an increase in
401
ROS production at 0 h for the vitrified group, probably because of the oxidative
402
stress produced by the vitrification-warming process. However, these levels did not
403
persist in time and were continued with a significant decrease after 3 h of incubation
404
post-warming, reaching lower levels than the control and persisting at 21 h. The
405
decrease in ROS levels, cytosolic oxidative activity and quantification of active
406
mitochondria observed in both groups coincides with that observed in a previous
407
study, in which non-activated oocytes presented decreasing levels of both ROS and
408
cytosolic oxidative activity throughout 24 h post-maturation [36]. This suggests that
409
this behavior is related to oocytes going through an ageing process.
410
The redox state, which was determined by NAD(P)H autofluorescence,
411
showed no differences between vitrified and control groups. A peak at 21 h post-
412
warming was recorded for both control and vitrified oocytes, which might result
413
from a quieter metabolic state [37]. This statement is supported by the results of a
414
previous study in bovine oocytes, which suggested that tricarboxylic acid cycle
415
activity would be related to NAD(P)H levels [24].
416
Finally, functional studies were carried out to evaluate oocyte competence
417
after the vitrification-warming process. It has been described that vitrification affects
418
the normal oocyte spindle configuration [6, 11]. Therefore, we studied the
419
metaphase II recovery time and found that around 3 and 4 h of incubation post-
420
warming are necessary to achieve a higher recovery rate. As regards oocyte
17
421
competence, we observed that although vitrified oocytes could cleave after
422
fertilization, the cleavage rate diminished respect to that of controls and,
423
subsequently, embryo development was adversely affected by this procedure. We
424
also observed that the partial denudation of the oocytes, done before IVF in the
425
control group, negatively affected the cleavage rate and embryo development,
426
indicating that the low rates observed are a result of both the vitrification-warming
427
procedure and partial denudation. In line with these results, Hwang and Hochi
428
reviewed that the integrity of cumulus cells after vitrification is an important factor
429
to harvest cytoplasmically matured oocytes [38]. Several groups have reported the
430
possibility of cryopreserving bovine oocytes, but subsequent embryo development in
431
most of these studies has remained low, ranging from 0 to 15% [33, 39-44]. Only
432
few authors have reached higher rates with other vitrification methods, but also with
433
lower blastocyst rates respect to fresh embryos [30, 45]. Although we did not
434
observe macrostructural changes in vitrified-warmed oocytes, we cannot discard
435
ultrastructural changes that could affect developmental competence, as suggested by
436
other authors [29-31]. On the other hand, Cryotech® has successfully been used in
437
the vitrification of human oocytes, but there are important differences in the
438
characteristics of bovine and human oocytes that must be taken into account. Bovine
439
oocytes have a higher content of lipids than human oocytes, which makes them more
440
sensitive to cryopreservation [46]. Moreover, bovine oocytes are particularly
441
sensitive to cytoskeleton damages, such as alterations to the meiotic spindle, as a
442
consequence of cryopreservation [6, 47]. When subjected to parthenogenetic
443
activation, no differences were observed in the cleavage rates between control and
444
vitrified-warmed oocytes. This suggests that the interaction between vitrified-
18
445
warmed oocytes and spermatozoa could negatively be affected by the vitrification
446
process, as reported by other authors [48].
447
In conclusion, this study shows that it is possible to vitrify bovine oocytes,
448
given that their morphology and viability could be maintained through the
449
vitrification–warming process and 21 h in vitro post warming incubation. Our results
450
also suggest that the metabolic changes observed in bovine oocytes as a
451
consequence of vitrification and warming, represented mainly by variations in the
452
quantification of active mitochondria and levels of ROS production after warming,
453
could be in part responsible for their diminished developmental competence.
454
Therefore, the protocol must still be improved to avoid variations in oocyte
455
metabolism that could reduce their developmental competence.
456 457
5. Acknowledgments
458
This work was supported by a grant of the University of Buenos Aires (UBACyT
459
20020130100693BA 2014/2017), Argentina.
460
6. Bibliography
461
[1] Wang Y, Xiao Z, Li L, Fan W, Li SW. Novel needle immersed vitrification: a
462
practical and convenient method with potential advantages in mouse and human ovarian
463
tissue cryopreservation. Hum Reprod 2008;23:2256-65.
464
[2] Gutnisky C, Alvarez GM, Cetica PD, Dalvit GC. Evaluation of the Cryotech
465
Vitrification Kit for bovine embryos. Cryobiology 2013;67:391-3.
466
[3] Do VH, Walton S, Catt S, Taylor-Robinson AW. A comparative analysis of the
467
efficacy of three cryopreservation protocols on the survival of in vitro-derived cattle
468
embryos at pronuclear and blastocyst stages. Cryobiology 2017;77:58-63.
469
[4] Gupta A, Singh J, Dufort I, Robert C, Dias FCF, Anzar M. Transcriptomic
470
difference in bovine blastocysts following vitrification and slow freezing at morula
471
stage. PLoS ONE 2017;12:e0187268.
472
[5] Saragusty J, Arav A. Current progress in oocyte and embryo cryopreservation by
473
slow freezing and vitrification. Reproduction 2011;141:1-19. 19
474
[6] Morato R, Izquierdo D, Paramio MT, Mogas T. Embryo development and structural
475
analysis of in vitro matured bovine oocytes vitrified in flexipet denuding pipettes.
476
Theriogenology 2008;70:1536-43.
477
[7] Rusciano G, De Canditiis C, Zito G, Rubessa M, Roca MS, Carotenuto R, et al.
478
Raman-microscopy investigation of vitrification-induced structural damages in mature
479
bovine oocytes. PLoS ONE 2017;12:e0177677.
480
[8] Wang N, Hao HS, Li CY, Zhao YH, Wang HY, Yan CL, et al. Calcium ion
481
regulation by BAPTA-AM and ruthenium red improved the fertilisation capacity and
482
developmental ability of vitrified bovine oocytes. Sci Rep 2017;7:10652.
483
[9] Yan CL, Fu XW, Zhou GB, Zhao XM, Suo L, Zhu SE. Mitochondrial behaviors in
484
the vitrified mouse oocyte and its parthenogenetic embryo: effect of Taxol pretreatment
485
and relationship to competence. Fertil Steril 2010;93:959-66.
486
[10] Zhao XM, Fu XW, Hou YP, Yan CL, Suo L, Wang YP, et al. Effect of vitrification
487
on mitochondrial distribution and membrane potential in mouse two pronuclear (2-PN)
488
embryos. Mol Reprod Dev 2009;76:1056-63.
489
[11] Chen SU, Lien YR, Cheng YY, Chen HF, Ho HN, Yang YS. Vitrification of
490
mouse oocytes using closed pulled straws (CPS) achieves a high survival and preserves
491
good patterns of meiotic spindles, compared with conventional straws, open pulled
492
straws (OPS) and grids. Hum Reprod 2001;16:2350-6.
493
[12] Castillo-Martin M, Bonet S, Morato R, Yeste M. Supplementing culture and
494
vitrification-warming media with l-ascorbic acid enhances survival rates and redox
495
status of IVP porcine blastocysts via induction of GPX1 and SOD1 expression.
496
Cryobiology 2014;68:451-8.
497
[13] Dehghani-Mohammadabadi M, Salehi M, Farifteh F, Nematollahi S, Arefian E,
498
Hajjarizadeh A, et al. Melatonin modulates the expression of BCL-xl and improve the
499
development of vitrified embryos obtained by IVF in mice. J of Assist Reprod Genet
500
2014;31:453-61.
501
[14] Zhao XM, Hao HS, Du WH, Zhao SJ, Wang HY, Wang N, et al. Melatonin inhibits
502
apoptosis and improves the developmental potential of vitrified bovine oocytes. J Pineal
503
Res 2016;60:132-41.
504
[15] Sutovsky P, Schatten G. Depletion of glutathione during bovine oocyte maturation
505
reversibly blocks the decondensation of the male pronucleus and pronuclear apposition
506
during fertilization. Biol Reprod 1997;56:1503-12.
20
507
[16] Trapphoff T, Heiligentag M, Simon J, Staubach N, Seidel T, Otte K, et al.
508
Improved cryotolerance and developmental potential of in vitro and in vivo matured
509
mouse oocytes by supplementing with a glutathione donor prior to vitrification. Mol
510
Hum Reprod 2016;22:867-81.
511 512 513
[17] Segovia Y, Victory N, Peinado I, García Valverde LM, García M, Aizpurua J, Monzó A, Gómez- Torres MJ. Ultrastructural characteristics of human oocytes vitrified before and after in vitro maturation. J Reprod Dev 2017; 63(4): 377-382.
514 515 516
[18] Stimpfel M, Vrtacnik- Bokal E, Virant- Klun. No difference in mitochondrial distribution is observed in human oocytes after cryopreservation. Arch Gynecol Obstet 2017; 296: 373-381.
517 518
[19] Gandhi G, Kuwayama M, Kagalwala S, Pangerkar P. Appendix A: Cryotech® Vitrification Thawing. Methods Mol Biol 2017; 1568:281-295.
519
[20] Cryotech® September, 2019. www.cryotechlab.com.
520
[21] Alvarez GM, Dalvit GC, Achi MV, Miguez MS, Cetica PD. Immature oocyte
521
quality and maturational competence of porcine cumulus-oocyte complexes
522
subpopulations. Biocell 2009;33:167-77.
523
[22] Alvarez GM, Casiró S, Gutnisky C, Dalvit GC, Sutton Mc-Dowall ML, Thompson
524
J., Cetica PD. Implications of glycolytic and pentose phosphate pathways on the
525
oxidative status and active mitochondria of the porcineoocyte during IVM.
526
Theriogenology 2016;86:2096-2106.
527
[23] Morado SA, Cetica PD, Beconi MT, Dalvit GC. Reactive oxygen species in bovine
528
oocyte maturation in vitro. Reprod Fertil Dev 2009;21:608-14.
529
[24] Sutton-McDowall ML, Purdey M, Brown HM, Abell AD, Mottershead DG, Cetica
530
PD, et al. Redox and anti-oxidant state within cattle oocytes following in vitro
531
maturation with bone morphogenetic protein 15 and follicle stimulating hormone. Mol
532
Reprod Dev 2015;82:281-94.
533
[25] Gutnisky C, Dalvit GC, Thompson JG, Cetica PD. Pentose phosphate pathway
534
activity: effect on in vitro maturation and oxidative status of bovine oocytes. Reprod
535
Fertil Dev 2014;26:931-42.
536
[26] Takahashi Y, First NL. In vitro development of bovine one-cell embryos: Influence
537
of glucose, lactate, pyruvate, amino acids and vitamins. Theriogenology 1992;37:963-
538
78.
539
[27] Hallap T, Haard M, Jaakma U, Larsson B, Rodriguez-Martinez H. Does cleansing
540
of frozen-thawed bull semen before assessment provide samples that relate better to
541
potential fertility? Theriogenology 2004;62:702-13. 21
542
[28] Grupen CG, Mau JC, McIlfatrick SM, Maddocks S, Nottle MB. Effect of 6-
543
dimethylaminopurine on electrically activated in vitro matured porcine oocytes. Mol
544
Reprod Dev 2002;62:387-96.
545
[29] Luna HS, Ferrari I, Rumpf R. Influence of stage of maturation of bovine oocytes at
546
time of vitrification on the incidence of diploid metaphase II at completion of
547
maturation. Anim Reprod Sci 2001;68:23-8.
548
[30] Chasombat J, Nagai T, Parnpai R, Vongpralub T. Pretreatment of in vitro matured
549
bovine oocytes with docetaxel before vitrification: Effects on cytoskeleton integrity and
550
developmental ability after warming. Cryobiology 2015;71:216-23.
551
[31] Palmerini MG, Antinori M, Maione M, Cerusico F, Versaci C, Nottola SA, et al.
552
Ultrastructure of immature and mature human oocytes after cryotop vitrification. J
553
Reprod Develop 2014;60:411-20.
554
[32] Succu S, Leoni GG, Bebbere D, Berlinguer F, Mossa F, Bogliolo L, et al.
555
Vitrification devices affect structural and molecular status of in vitro matured ovine
556
oocytes. Mol Reprod Dev 2007;74:1337-44.
557
[33] Succu S, Gadau SD, Serra E, Zinellu A, Carru C, Porcu C, et al. A recovery time
558
after warming restores mitochondrial function and improves developmental competence
559
of vitrified ovine oocytes. Theriogenology 2018;110:18-26.
560
[34] Gupta MK, Uhm SJ, Lee HT. Effect of vitrification and beta-mercaptoethanol on
561
reactive oxygen species activity and in vitro development of oocytes vitrified before or
562
after in vitro fertilization. Fertil Steril 2010;93:2602-7.
563
[35] Ren L, Fu B, Ma H, Liu D. Effects of mechanical delipation in porcine oocytes on
564
mitochondrial distribution, ROS activity and viability after vitrification. Cryo letters.
565
2015;36:30-6.
566
[36] Morado S, Cetica P, Beconi M, Thompson JG, Dalvit G. Reactive oxygen species
567
production and redox state in parthenogenetic and sperm-mediated bovine oocyte
568
activation. Reproduction 2013;145:471-8.
569
[37] Madrid Gaviria S, Morado SA, López Herrera A, Restrepo Betancur G, Urrego
570
Álvarez RA, Echeverri Zuluaga J, et al. Resveratrol supplementation promotes recovery
571
of lower oxidative metabolism after vitrification and warming of in vitro produced
572
bovine embryos. Reprod Fertil Devel 2019;31:521-8.
573
[38] Hwang I, Hochi S. Recent progress of cryopreservation of bovine oocyte. Biomed
574
Res Int 2014; Article ID 570647.
22
575
[39] Diez C, Duque P, Gomez E, Hidalgo CO, Tamargo C, Rodriguez A, et al. Bovine
576
oocyte vitrification before or after meiotic arrest: effects on ultrastructure and
577
developmental ability. Theriogenology 2005;64:317-33.
578
[40] Prentice JR, Singh J, Dochi O, Anzar M. Factors affecting nuclear maturation,
579
cleavage and embryo development of vitrified bovine cumulus-oocyte complexes.
580
Theriogenology 2011;75:602-9.
581
[41] Prentice-Biensch JR, Singh J, Mapletoft RJ, Anzar M. Vitrification of immature
582
bovine cumulus-oocyte complexes: effects of cryoprotectants, the vitrification
583
procedure and warming time on cleavage and embryo development. Reprod Biol
584
Endocrinol 2012;10:73.
585
[42] Bulgarelli DL, Vireque AA, Pitangui-Molina CP, Silva-de-Sa MF, de Sa Rosa
586
ESACJ. Reduced competence of immature and mature oocytes vitrified by Cryotop
587
method: assessment by in vitro fertilization and parthenogenetic activation in a bovine
588
model. Zygote. 2017;25:222-30.
589
[43] Ortiz-Escribano N, Smits K, Piepers S, Van den Abbeel E, Woelders H, Van Soom
590
A. Role of cumulus cells during vitrification and fertilization of mature bovine oocytes:
591
Effects on survival, fertilization, and blastocyst development. Theriogenology
592
2016;86:635-41.
593
[44] Spricigo JF, Morais K, Ferreira AR, Machado GM, Gomes AC, Rumpf R, et al.
594
Vitrification of bovine oocytes at different meiotic stages using the Cryotop method:
595
assessment of morphological, molecular and functional patterns. Cryobiology
596
2014;69:256-65.
597
[45] Vajta G, Holm P, Kuwayama M, Booth PJ, Jacobsen H, Greve T, et al. Open
598
Pulled Straw (OPS) vitrification: a new way to reduce cryoinjuries of bovine ova and
599
embryos. Mol Reprod Dev 1998;51:53-8.
600
[46] Somfai T, Kikuchi K, Nagai T. Factors affecting cryopreservation of porcine
601
oocytes. J Reprod Dev 2012; 58(1): 17-24.
602 603 604
[47] Bogliolo L, Ariu F, Fois S, Rosati I, Zedda MT, Leoni G, Succu S, Pau S, Ledda S. Morphological and biochemical analysis of immature ovine oocytes vitrified with or without cumulus cells. Theriogenology 2017; 68(8): 1138-49.
605
[48] Wiesak T, Wasielak M, Zlotkowska A, Milewski R. Effect of vitrification on the
606
zona pellucida hardening and follistatin and cathepsin B genes expression and
607
developmental competence of in vitro matured bovine oocytes. Cryobiology
608
2017;76:18-23. 23
609
24
Caption of the figures Fig 1. Scheme of the experimental design showing the three groups involved in the work and the asynchrony between them: Control, Vitrified-warmed and IVF control oocytes. Fig 2: Representative photographs of fresh and vitrified-warmed oocytes (x120) used for biochemical evaluations. (a) to (c) fresh oocytes at 0, 3 and 21h, (A) to (C) vitrifiedwarmed oocytes at 0, 3 and 21h stained with RedoxSensor Red CC1; (d) to (f) fresh oocytes at 0, 3 and 21h, (D) to (F) vitrified-warmed oocytes at 0, 3 and 21h stained with Mitotracker Green; (g) to (i) fresh oocytes at 0, 3 and 21h, (G) to (I) vitrified-warmed oocytes at 0, 3 and 21h stained with DCHFDA; (j) to (l) fresh oocytes at 0, 3 and 21h, (J) to (L) vitrified-warmed oocytes at 0, 3 and 21h showing NAD(P)H autofluorescence. Figure 3. A. Unrecovered nuclear material and B. Metaphase II plate, recovered after 3 h incubation post warming. Arrow indicate the presence of the first polar body and * indicate metaphase II chromatin configuration. Magnification (x100). Fig. 4 a, b. Cytosolic oxidative status (a) and active mitochondria (b) of control (white bars) and vitrified- warmed oocytes (grey bars) incubated for 0, 3 and 21 h post warming. Data are the mean ± s.e.m. (n=30–40 COCs for each treatment in three replicates). Bars of the same colour with different letters differ significantly (P<0.05). The asterisks indicate significant differences between treatments at the same time point. Fig. 5. Reactive oxygen species (ROS) of control (white bars) and vitrified- warmed oocytes (grey bars) incubated for 0, 3 and 21 h post warming. Data are the mean ± s.e.m. (n=30–40 COCs for each treatment in three replicates). Bars of the same colour with different letters differ significantly (P<0.05). The asterisks indicate significant differences between treatments at the same time point. Fig. 6. Redox state of control (white bars) and vitrified- warmed oocytes (grey bars) for 0, 3 and 21 h post warming. Data are the mean ± s.e.m. (n=30–40 COCs for each treatment in three replicates). Bars of the same colour with different letters differ significantly (P<0.05).
Highlights
•
Oocyte vitrification with Cryotech® kit does not affect oocyte morphology nor viability.
•
No differences in oxidative activity were found between control and vitrifiedwarmed oocytes at each studied time point, while differences between the studied time points were observed. Quantification of active mitochondria was higher in the vitrified- warmed oocytes than control oocytes at 0 and 3 h after warming. ROS levels were higher at 0h in the vitrified- warmed oocytes than in control oocytes. Oocyte vitrification and partial denudation affect the cleavage and blastocyst rates, showing a decrease in these parameters.
• • •
Author contributions
Gutnisky Cynthia: Methodology, investigation, formal analysis, writing original draft, reviewing, editing and visualization. Morado Sergio: Methodology, investigation, reviewing, editing and visualization. Gadze Tomas: Investigation. Donato Antonella: Investigation. Alvarez Gabriel: Investigation. Dalvit Gabriel: Supervision, project administration, funding acquisition. Cetica Pablo: Supervision, project administration, funding acquisition, reviewing, editing and visualization.